Blastocystosis

Author(s):  
Manoj K. Puthia ◽  
Kevin S. Tan

Blastocystis , the causative agent of blastocystosis, is an intestinal protozoan commonly identified in stool specimens of patients. It is one of the most common parasites inhabiting the human intestinal tract. Clinical symptoms attributed to Blastocystis include recurrent watery diarrhoea, mucous diarrhoea, vomiting, abdominal cramps and flatulence. Blastocystis infects both children and adults and its geographical distribution appears to be global with prevalence ranging from 30 to 50% in developing countries (Stenzel and Boreham 1996).Blastocystis was first described as a distinct organism in 1911 and the name B. enterocola was proposed for this organism (Alexeieff 1911). It was isolated from human faeces and the name B. hominis was coined (Brumpt 1912). At first, it was described as a harmless intestinal yeast and ignored for many decades. Its association with human disease was suggested by a number of reports and eventually work by Zierdt (1991) increased the awareness of Blastocystis infections in humans.In spite of its description about a century ago, the exact role of Blastocystis as a cause of human disease is uncertain. A number of clinical and epidemiological studies implicate the parasite as a potential pathogen (Al-Tawil et al. 1994; El-Shazly et al. 2005; Garavelli et al. 1991; Logar et al. 1994) while others exonerate it as an etiology of intestinal disease (Chen et al. 2003; Leder et al. 2005; Shlim et al. 1995). Significant progress has been achieved on descriptions of the morphology and genetic diversity of Blastocystis but most aspects of its life cycle, molecular biology, and athogenicity remain unresolved (Stenzel and Boreham 1996; Tan 2004).

CNS Spectrums ◽  
1998 ◽  
Vol 3 (8) ◽  
pp. 46-49 ◽  
Author(s):  
Liat Stern ◽  
Joseph Zohar ◽  
Thalma Hendler ◽  
Iulian Ianco ◽  
Yehuda Sasson

Obsessive-compulsive disorder (OCD) is a psychiatric disorder in which the patient suffers from recurrent intrusive ideas, impulses, thoughts (obsessions), and/or patterns of behavior (compulsions) that are ego-alien and produce anxiety if resisted. The ego-dystonic nature of OCD is one of the hallmarks of this disorder. OCD can be a disabling condition because the obsessions and compulsions are time-consuming and interfere with patients' everyday activities and their relationships with friends and family. In severe cases, OCD conflicts even with the simplest tasks of daily living.Research interest in OCD has been growing steadily in the past decade. A search on MEDLINE reveals an over 300% increase in citations on OCD from 1986 to 1998. These range across the spectrum of research fields, from genetic studies, brain imaging, and neurobiological research examining the underlying pathogenesis of OCD to epidemiological studies evaluating the course of clinical symptoms, comorbidities, and outcomes. Each area represents an important piece in the complex jigsaw puzzle of OCD.


2014 ◽  
Vol 122 (8) ◽  
pp. 817-822 ◽  
Author(s):  
Sergio S.C. DC.Rubin ◽  
Pradeep Alava ◽  
Ivar Zekker ◽  
Gijs Du Laing ◽  
Tom Van de Wiele

2021 ◽  
Vol 271 ◽  
pp. 03047
Author(s):  
Yu Xihe

Depression is one of the most common mental disorders. It refers to a kind of mood disorder with significant and lasting depression as the main clinical symptoms caused by various reasons. Its core symptoms are depression, loss of interest, lack of energy, often accompanied by physical symptoms, cognitive symptoms and so on. Serious patients have the risk of self injury and suicide. Most drug treatments focus on changing neurotransmitter activity in the brain, and Probiotics are a kind of active microorganisms which are beneficial to the host. They are colonized in the human intestinal tract and reproductive system and can produce exact health effects, thus improving the balance of the host's microecology and playing a beneficial role. Ingestion of certain probiotics seems to be a potential treatment for depression.


2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Sepideh Abdollahi ◽  
Pantea Izadi

: In December 2019, the new virus, COVID-19, emerged and led to a pandemic respiratory acute disease. Almost all countries have experienced different rates of morbidity and mortality. These differences can be attributed to factors such as a diagnostic test capacity for COVID-19 and the health system efficiency. Besides the differences between countries related to the COVID-19 management, different patients represent a diverse range of clinical symptoms, from outpatient to patients admitted to the intensive care unit (ICU) due to the severity of symptoms. To gain deeper insights into such disparities in the severity of COVID-19 clinical presentations, epidemiological studies have reported risk factors such as old age, male sex, underlying chronic diseases such as diabetes, inflammatory and cardiovascular diseases, which have a bearing on susceptibility to COVID-19. In addition to these risk factors, the molecular mechanism involved in the virus entry process has been under investigation. Apart from a well-known protein called ACE2 (angiotensin-converting enzyme 2), which plays the receptor role for COVID-19, another essential protein in this pathway is TMPRSS2 (transmembrane protease, serine 2). This protease has a crucial role in effective membrane integration between the virus and the target cell. This process can affect the severity of the infection and the mortality rate of the disease. Thus, it seems that understanding the role of TMPRSS2 in COVID-19 infection can help better management by designing TMPRSS2 inhibitors drugs. Given the variants of the TMPRSS2 gene, which are associated with the severity of symptoms, people exposed to severe forms of this disease can be identified before the deterioration of the disease to adopt appropriate therapeutic approaches. Therefore, this study focused on the different levels of the TMPRSS2 interactions with COVID-19 virus and disease severity.


2020 ◽  
Vol 84 (2) ◽  
Author(s):  
Feng Zhang ◽  
Fang He ◽  
Li Li ◽  
Lichun Guo ◽  
Bin Zhang ◽  
...  

SUMMARY The substantial discrepancy between the strong effects of functional foods and various drugs, especially traditional Chinese medicines (TCMs), and the poor bioavailability of these substances remains a perplexing problem. Understanding the gut microbiota, which acts as an effective bioreactor in the human intestinal tract, provides an opportunity for the redefinition of bioavailability. Here, we discuss four different pathways associated with the role of the gut microbiota in the transformation of parent compounds to beneficial or detrimental small molecules, which can enter the body’s circulatory system and be available to target cells, tissues, and organs. We further describe and propose effective strategies for improving bioavailability and alleviating side effects with the help of the gut microbiota. This review also broadens our perspectives for the discovery of new medicinal components.


Pathogens ◽  
2019 ◽  
Vol 8 (3) ◽  
pp. 116 ◽  
Author(s):  
Hemphill ◽  
Müller ◽  
Müller

Protozoan parasites can infect the human intestinal tract causing serious diseases. In the following article, we focused on the three most prominent intestinal protozoan pathogens, namely, Giardia lamblia, Entamoeba histolytica, and Cryptosporidium parvum. Both C. parvum and G. lamblia colonize the duodenum, jejunum, and ileum and are the most common causative agents of persistent diarrhea (i.e., cryptosporidiosis and giardiasis). Entamoeba histolytica colonizes the colon and, unlike the two former pathogens, may invade the colon wall and disseminate to other organs, mainly the liver, thereby causing life-threatening amebiasis. Here, we present condensed information concerning the pathobiology of these three diseases.


2020 ◽  
Vol 20 (3) ◽  
pp. 396-400
Author(s):  
Soghra Viesy ◽  
Jahangir Abdi ◽  
Karimeh Haghani ◽  
Reza Valizadeh ◽  
A. Mirzaei

Giardia lamblia has proved to be the most common intestinal protozoan parasite in humans that causes giardiasis. Given the high mutations in the genome of this parasite, the present study was conducted to determine the prevalence of Giardia lamblia subtypes and their relationship with clinical symptoms in patients who appear to have giardiasis. In 69 stool specimens with an appropriate number of giardia cysts, the DNA was first purified, and the genotype was then determined based on the glutamate dehydrogenase (gdh) gene sequence using PCR-RFLP. Data were collected on the clinical symptoms of the patients through a questionnaire, and their relationship with molecular results was studied. Four samples (5.8%) were found to be of subtype AI, 51 (73.9%) of subtype AII and 14 (20.3 %) of subtype BIII. No BIV subtype was found in the present study. A correlation was observed between Giardia lamblia genotypes (AI, AII and BIII) and abdominal pain. All of the people (100%) who had the AI genotype (i.e. the zoonosis subtype) had been losing weight. There was a significant correlation between weight loss and the AI subtype. All of the people (100%) infected with the BIII genotype experienced diarrhea, and this genotype was found to be associated with diarrhea. The present study found abdominal pain to be the most common symptom of giardiasis in Ilam province. Moreover, humans were found to be the main reservoir for giardia lamblia, although zoonosis subtypes such as AI and BIII still exist in the region and pose a risk for a giardiasis epidemic.


2011 ◽  
Vol 11 (1) ◽  
pp. 130-133
Author(s):  
Astra Zviedre ◽  
Arnis Engelis ◽  
Mohit Kakar ◽  
Aigars Pētersons

Potential Role of Cytokines in Children with Acute Appendicitis and Acute Mesenteric Lymphadenitis Although, AAP and AML have different etiological factors, clinical symptoms are very much similar but treatment tactics in both the disease differ a lot. In case of AML, treatment is more conservative and does not require hospitalization while in case of AAP immediate hospitalization and maybe further surgery can be mandatory. With the identification of group of cytokines serum inflammatory mediators IL-8, IL-10, IL-12[p70], IL-17, TNF-a and MCP-1, it is believed early and proper diagnosis of AAP in the near future. Research of cytokines-serum inflammatory mediators has opened new opportunities for an early detection and differentiation of these two diseases in children.


Sign in / Sign up

Export Citation Format

Share Document